{
    "root": "3429c6eb-3eea-6e78-e063-6294a90afa75",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Aripiprazole",
    "value": "20250502",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TARTARIC ACID",
            "code": "W4888I119H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "ARIPIPRAZOLE",
            "code": "82VFR53I78",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31236"
        }
    ],
    "indications": {
        "text": "aripiprazole tablets indicated treatment : schizophrenia irritability associated autistic disorder treatment tourette \u2019 disorder",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "autistic disorder (DOID:12849)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12849"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "administer daily without regard meals ( 2 ) initial dose recommended dose maximum dose schizophrenia \u2013 adults ( 2.1 ) 10 15 mg/day 10 15 mg/day 30 mg/day schizophrenia \u2013 adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day irritability associated autistic disorder \u2013 pediatric patients ( 2.4 ) 2 mg/day 5 10 mg/day 15 mg/day tourette \u2019 disorder \u2013 ( 2.5 ) patients < 50 kg 2 mg/day 5 mg/day 10 mg/day patients \u2265 50 kg 2 mg/day 10 mg/day 20 mg/day known cyp2d6 poor metabolizers : half usual dose . ( 2.6 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "autistic disorder (DOID:12849)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12849"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "aripiprazole tablets usp , 5 mg , supplied blue light blue colored , mosaic appearance , modified rectangle shaped , uncoated tablet debossing \u201c an897 \u201d \u201c 5 \u201d one side plain side . available follows : ndc : 70518-0970-00 ndc : 70518-0970-01 ndc : 70518-0970-02 ndc : 70518-0970-03 packaging : 30 1 blister pack packaging : 30 1 box packaging : 1 1 pouch packaging : 180 1 bottle plastic storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] tightly closed containers . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "aripiprazole tablets contraindicated patients history hypersensitivity reaction aripiprazole . ranged pruritus/urticaria anaphylaxis [ ( 6.2 ) ] .",
    "indications_original": "Aripiprazole Tablets are indicated for the treatment of:\n                  \n                     Schizophrenia\n                     Irritability Associated with Autistic Disorder\n                     Treatment of Tourette\u2019s Disorder",
    "contraindications_original": "Administer once daily without regard to meals ( 2 ) Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults ( 2.1 ) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia \u2013 adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day Irritability associated with autistic disorder \u2013 pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette\u2019s Disorder \u2013 ( 2.5 ) Patients < 50 kg 2 mg/day 5 mg/day 10 mg/day Patients \u2265 50 kg 2 mg/day 10 mg/day 20 mg/day Known CYP2D6 poor metabolizers: Half of the usual dose. ( 2.6 )",
    "warningsAndPrecautions_original": "Aripiprazole tablets USP,\u00a05 mg,\u00a0are supplied as blue to light blue colored, mosaic appearance, modified rectangle shaped, uncoated tablet with debossing \u201cAN897\u201d and \u201c5\u201d on one side and plain on the other side.\n                  They are available as follows:\n                  \n                  NDC: 70518-0970-00\n                  NDC: 70518-0970-01\n                  NDC: 70518-0970-02\n                  NDC: 70518-0970-03\n                  PACKAGING: 30 In 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  PACKAGING: 180 in 1 BOTTLE PLASTIC\n                  \n                  Storage\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted between 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature] in tightly closed containers.\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Aripiprazole tablets are contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis\n \n  [see\n  \n   \n                           Adverse Reactions (6.2)\n                        ]\n \n  .",
    "drug": [
        {
            "name": "Aripiprazole",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31236"
        }
    ]
}